Iron Triangle Partners »

Bio-techne Corporation shares owned by Iron Triangle Partners

Quarter-by-quarter ownership of Bio-techne Corporation (TECH) shares owned by Iron Triangle Partners from 13F filings

Historical chart of Iron Triangle Partners investment in Bio-techne Corporation

Tip: Access up to 7 years of quarterly data

All positions including Bio-techne Corporation held by Iron Triangle Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-techne Corporation by Iron Triangle Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $28M 467k 58.81
2025-03-31 $15M 250k 58.63

More positions owned by Iron Triangle Partners

Charles River Laboratories (CRL)
Intuitive Surgical Com New (ISRG)
Repligen Corporation (RGEN)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Veracyte (VCYT)
Boston Scientific Corporation (BSX)
Waters Corporation (WAT)
Brookdale Senior Living (BKD)
Eli Lilly & Co. (LLY)
Bruker Corporation (BRKR)
Vertex Pharmaceuticals Incorporated (VRTX)
CVS Caremark Corporation (CVS)
Fortrea Hldgs Common Stock (FTRE)
Merit Medical Systems (MMSI)
Brightspring Health Svcs (BTSG)

View all positions for Iron Triangle Partners

Top funds holding Bio-techne Corporation

Vanguard Group
BlackRock
State Street Corporation
Wellington Management Company
Geode Capital Management
Massachusetts Financial Services
Maverick Capital
Invesco
Neuberger Berman Group
Select Equity
Ameriprise Financial
Mairs and Power
Df Dent & Co
Bamco
Mackenzie Financial

View all funds holding Bio-techne Corporation